Atlas Trials

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Clinical trial NCT05524571 · COMPLETED

Trial details

NCT number
NCT05524571
Sponsor
Immunovant Sciences GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease
Start date
2023-01-05
Primary completion
2026-02-03
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.